Alembic Pharmaceuticals completes ANVISA GMP audit for API-II Facility in Panelav

11 Dec 2024 Evaluate

Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-II Facilty at Panelav for its 8 APIs. The inspection was conducted from September 16, 2024 to September 20, 2024.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company.


Alembic Pharma Share Price

766.95 5.20 (0.68%)
22-Jan-2026 13:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1616.70
Dr. Reddys Lab 1216.00
Cipla 1369.95
Zydus Lifesciences 885.00
Lupin 2169.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×